POM-V Prescription Required Companion Animal

Benazecare Flavour 5 mg Tablets for Dogs and Cats

Active ingredient: Benazepril Hydrochloride

Form

Tablet

Species

Cats Dogs

Manufacturer

Ecuphar NV

VMD MA No.

32742/4038

What it's used for

Cats: Reduction of proteinuria associated with chronic kidney disease.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Benazepril Hydrochloride

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Benazecare Flavour 5 mg Tablets for Dogs and Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Cats:
Reduction of proteinuria associated with chronic kidney disease.

The veterinary medicinal product should be given orally once daily, with or without
food. The duration of treatment is unlimited.
Dogs:
The veterinary medicinal product should be administered orally at a minimum dose of
0.25 mg (range 0.25 - 0.5) benazepril hydrochloride/kg body weight once daily,
according to the following table:
BENAZECARE

FLAVOUR 5 mg
Weight of dog
(kg)
Standard
Dose
Double Dose5 – 10
> 10 – 20
0.5 tablet
1 tablet
1 tablet
2 tablets
The dose may be doubled, still administered once daily, to a minimum dose of
0.5 mg/kg (range 0.5 - 1.0), if judged clinically necessary and advised by the
veterinary surgeon.
Cats:
The veterinary medicinal product should be administered orally at a minimum dose of
0.5 mg (range 0.5 - 1.0) benazepril hydrochloride/kg body weight once daily
according to the following table:
Weight of cat (kg)BENAZECARE FLAVOUR 5 mg2.5 – 50.5 tablet> 5 - 101 tablet

Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Do not use in cases of hypotension, hypovolaemia, hyponatraemia or acute renal
failure.
Do not use in cases of cardiac output failure due to aortic or pulmonary stenosis.
Do not use during pregnancy or lactation (section 3.7).
AN: 02966/2024 & 02968/2024

Dogs:
Undetermined frequency
(cannot be estimated from the
available data):
Vomiting
Incoordination
Fatigue
Elevated creatinine
1
Transient
In dogs with chronic kidney disease, at the start of therapy. A moderate increase in
plasma creatinine concentrations following the administration of ACE inhibitors is
compatible with the reduction in glomerular hypertension induced by these agents
and is therefore not necessarily a reason to stop therapy in the absence of other
signs.
In double-blind clinical trials in dogs with congestive heart failure, benazepril
hydrochloride was well tolerated with an incidence of adverse reactions lower than
observed in placebo-treated dogs.
AN: 02966/2024 & 02968/2024
Cats:
Rare
(1 to 10 animals / 10,000
animals treated):
Diarrhoea, Emesis
Anorexia, Dehydration, Lethargy
Undetermined frequency
(cannot be estimated from the
available data):
Elevated creatinine
Increased appetite, Weight gain
In cats with chronic kidney disease, at the start of therapy. A moderate increase in
plasma creatinine concentrations following the administration of ACE inhibitors is
compatible with the reduction in glomerular hypertension induced by these agents
and is therefore not necessarily a reason to stop therapy in the absence of other
signs.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

None.

Special precautions for safe use in the target species:
No evidence of renal toxicity of the veterinary medicinal product has been observed
(in dogs or cats) during clinical trials, however, as is routine in cases of chronic
kidney disease, it is recommended to monitor plasma creatinine, urea and
erythrocyte counts during therapy.
The efficacy and safety of benazepril hydrochloride
and cats below 2.5 kg body weight.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Pregnant women should take special care to avoid accidental oral exposure because
angiotensin converting enzyme (ACE) inhibitors have been found to affect the unborn
child during pregnancy in humans.
Special precautions for the protection of the environment:
Not applicable.

In dogs with congestive heart failure, benazepril hydrochloride
combination with digoxin, diuretics, pimobendan and anti-arrhythmic veterinary
medicinal products without demonstrable adverse interactions.
In humans, the combination of ACE inhibitors and Non-Steroidal Anti-Inflammatory
Drugs (NSAIDs) can lead to reduced anti-hypertensive efficacy or impaired renal
function. The combination of benazepril hydrochloride and other anti-hypertensive
agents (e.g. calcium channel blockers, or diuretics), anaesthetics or
sedatives may lead to additive hypotensive effects. Therefore, concurrent use of
NSAIDs or other medications with a hypotensive effect should be considered with
care. Renal function and signs of hypotension (lethargy, weakness etc.) should be
monitored closely and treated as necessary.
Interactions with potassium-preserving diuretics like spironolactone, triamterene or
amiloride cannot be ruled out. It is recommended to monitor plasma potassium levels
when using benazepril hydrochloride
diuretic because of the risk of hyperkalaemia.
AN: 02966/2024 & 02968/2024

Do not store above 25 C.
Store in a dry place.
Divided tablets should be stored in the blister pack. The blister pack should be
inserted back into the cardboard box.

Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.